This Article Full Text Full Text (PDF) Perspective on This Article Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Bhutani, M. Articles by Mao, L. PubMed Articles by Bhutani, M. Articles by Mao, L. Related Collections Epidemiology: Environmental Toxicology Early Detection Early Detection: Biomarkers: Discovery, Methodology, Validation Commentary

Oral Epithelium as a Surrogate Tissue for Assessing Smoking-Induced Molecular Alterations in the Lungs

Authors' Affiliations: Departments of ¹ Thoracic/Head and Neck Medical Oncology, ² Biostatistics and Applied Mathematics, and ³ Pulmonary Medicine, The University of Texas M. D. Anderson Cancer Center; and ⁴ Cancer Biology Program, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas

Requests for reprints: Li Mao, Department of Thoracic/Head and Neck Medical Oncology, Unit 432, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009. Phone: 713-792-6363; Fax: 713-792-1220; E-mail: lmao{at}mdanderson.org.

The lungs and oral cavity of smokers are exposed to tobacco carcinogens. We hypothesized that tobacco-induced molecular alterations in the oral epithelium are similar to those in the lungs, and thus the oral epithelium may be used as a surrogate tissue for assessing alterations in the lungs. We used methylation-specific PCR to analyze promoter methylation of the p16 and FHIT genes at baseline and 3 months after intervention in 1,774 oral and bronchial brush specimens from 127 smokers enrolled in a randomized placebo-controlled chemoprevention trial. The association between methylation patterns in oral tissues and bronchial methylation indices (methylated sites / total sites per subject) was analyzed in a blinded fashion. At baseline, promoter methylation in bronchial tissue was present in 23% of samples for p16, 17% for FHIT, and 35% for p16 and FHIT; these percentages were comparable to methylation in oral tissue: 19% (p16), 15% (FHIT), and 31% (p16 and FHIT). Data from both oral and bronchial tissues were available for 125 individuals, in whom the two sites correlated strongly with respect to alterations (P < 0.0001 for both p16 and FHIT). At baseline, the mean bronchial methylation index was far higher in patients with oral tissue methylation (in either of the two genes; 39 patients) than in patients without oral tissue methylation (86 patients): 0.53 ± 0.29 versus 0.27 + 0.26 methylation index (P < 0.0001). Similar correlations occurred at 3 months after intervention. Our results support the potential of oral epithelium as a surrogate tissue for assessing tobacco-induced molecular damage in the lungs and thus have important implications for designing future lung cancer prevention trials and for research into the risk and early detection of lung cancer.

Commentary

The Oral Cavity as a Molecular Mirror of Lung Carcinogenesis

David Sidransky
Cancer Prevention Research 2008 1: 12-14. [Full Text] [PDF]

This article has been cited by other articles:

				D. Sidransky The Oral Cavity as a Molecular Mirror of Lung Carcinogenesis Cancer Prevention Research, June 1, 2008; 1(1): 12 - 14. [Full Text] [PDF]